Income statement and cash flow are strong; balance sheet is moderate.
Next earnings: 2026-10-29 (AMC), EPS Forecast: $3.56
Upgraded from Sell to Hold in the Jun 2026 quarter: 68.2 → 71.0 (+2.8). This quarter: +2.8.
Change vs previous quarter.
Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.